Needham analyst Michael Matson reiterated a Buy rating on Paragon 28 (FNA - Research Report) today and set a price target of $24.00. The company's shares closed yesterday at $18.04.According to TipRanks, Matson is an analyst with an average return of -0.5% and a 45.22% success rate. Matson covers the Healthcare sector, focusing on stocks such as Medtronic, SurModics, and NeoGenomics.Currently, the analyst consensus on Paragon 28 is a Moderate Buy with an average price target of $27.00, a 49.67% upside from current levels. In a report released today, JMP Securities also reiterated a Buy rating on the stock with a $30.00 price target.
https://www.tipranks.com/news/blurbs/paragon-28-fna-receives-a-buy-from-needham?utm_source=advfn.com&utm_medium=referral